Insider · CIK 0001699488
Vikram Karnani
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC), DYN (Dyne Therapeutics, Inc.). First filing -, latest -.
In brief
Vikram Karnani files SEC Form 4 as CEO, president and director at COLL (COLLEGIUM PHARMACEUTICAL, INC), and also at DYN (Dyne Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Vikram Karnani has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +79,264 | $0.00 | $0 | 176,629 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +32,531 | $0.00 | $0 | 209,160 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -11,296 | $46.75 | $528k | 197,864 | Feb 12, 2026 |
| Dec 22, 2025 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +59,665 | $0.00 | $0 | 59,665 | Dec 23, 2025 |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -8,983 | $47.35 | $425k | 96,989 | Nov 14, 2025 |
| Nov 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +105,972 | $0.00 | $0 | 105,972 | Nov 14, 2024 |
| Nov 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Stock Option (Right to Purchase)derivative | +130,344 | $0.00 | $0 | 130,344 | Nov 14, 2024 |
Questions about Vikram Karnani
Answered from the filings on this page, as of the latest one.
Is Vikram Karnani buying or selling?
Vikram Karnani has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Vikram Karnani's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vikram Karnani has 0.
Where does Vikram Karnani file Form 4?
Vikram Karnani has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC) as President and CEO; DYN (Dyne Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.